# OnCo record nct06398444 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06398444/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06398444", "NCT06398444" ;
  schema:name "A Clinical Study of Lutetium[177Lu] Oxodotreotide Injection in Patients With Advanced Neuroendocrine Neoplasms"@en ;
  schema:description "A phase 2/3 trial of Lutetium[177Lu] Oxodotreotide Injection in neuroendocrine tumours, run by Sinotau Pharmaceutical Group, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06398444/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06398444> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "2/3" ;
  schema:startDate "2024-06-11" ;
  onco:cancers <https://onco.cc/cancers/neuroendocrine/> ;
  onco:companies <https://onco.cc/companies/sinotau-pharmaceutical/> .